Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Neoplasms × belinostat × Clear all

Phase

Status

Completed 5 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Lymphoma, T-Cell, Peripheral 3 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Immunoblastic Lymphadenopathy 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1

Interventions

Bevacizumab 36 Paclitaxel 27 Carboplatin 23 pembrolizumab 21 Specimen Handling 15 olaparib 13 Cisplatin 11 niraparib 10 Magnetic Resonance Spectroscopy 10 Cyclophosphamide 10 Blood Specimen Collection 10 fludarabine 8 Fulvestrant 8 Drug Therapy 8 Biopsy 8 Taxes 6 liposomal doxorubicin 5 Topotecan 5 Gemcitabine 5 Fluorouracil 5 Doxorubicin 5 mirvetuximab soravtansine 4 cemiplimab 4 aldesleukin 4 abemaciclib 4 Surveys and Questionnaires 4 Oxaliplatin 4 Interleukin-2 4 Immunoglobulin G 4 Hyperthermic Intraperitoneal Chemotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04315233 2025-04-22

CHARGE

University of Utah

Phase 1 Recruiting

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡